Raymond James Financial’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.72M Buy
109,811
+2,375
+2% +$94.4K ﹤0.01% 2779
2026
Q1
$4.14M Buy
107,436
+1,769
+2% +$72.9K ﹤0.01% 2743
2025
Q4
$4.35M Buy
105,667
+1,463
+1% +$57.8K ﹤0.01% 2629
2025
Q3
$3.88M Buy
104,204
+7,069
+7% +$257K ﹤0.01% 2644
2025
Q2
$3.54M Buy
97,135
+8,023
+9% +$291K ﹤0.01% 2622
2025
Q1
$3.44M Buy
89,112
+3,428
+4% +$136K ﹤0.01% 2591
2024
Q4
$3.25M Buy
+85,684
New +$3.42M ﹤0.01% 2612

Other funds holding BME

Raymond James Financial's BME Position: Q2 2026 in Review

Raymond James Financial increased its BlackRock Health Sciences Trust (BME) stake by 2.2% in Q2 2026, buying an estimated $94.4K and bringing the position to 109,811 shares worth $4.72M. The position accounts for ﹤0.01% of the portfolio, ranked #2779.

Raymond James Financial first reported a position in BME in Q4 2024 and has held it in 7 quarters since. 78 funds tracked by Wall St. Rank hold BME as of Q2 2026.

  • Raymond James Financial held 109,811 shares of BlackRock Health Sciences Trust worth $4.72M as of Q2 2026.
  • Raymond James Financial bought 2,375 BlackRock Health Sciences Trust shares in Q2 2026, an estimated $94.4K.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2779 holding.
  • Raymond James Financial first reported a position in BlackRock Health Sciences Trust in Q4 2024 and has held it in 7 quarters since.
  • 78 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.